← Open Payments lookup

LAURI WELCH: Open Payments

NPI 1972625788 · NORTH CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$46,710 in 154 payments from 23 companies in 2025. Trend: 2023 $13,973 · 2024 $26,839 · 2025 $46,710

Speaker / faculty: $31,310Consulting: $6,015Food & beverage: $5,012Travel & lodging: $4,373
CompanyPaymentsAmount
Madrigal Pharmaceuticals52$28,982
Gilead Sciences, Inc.36$14,343
Phathom Pharmaceuticals, Inc.7$1,882
Takeda Pharmaceuticals U.S.A., Inc.11$330
ABBVIE INC.10$291
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$158
Lilly USA, LLC3$149
NeurAxis, Inc.1$88
PFIZER INC.3$67
Ardelyx, Inc.3$59

Products named: REZDIFFRA, Epclusa, Livdelzi, VOQUEZNA, ENTYVIO, XIFAXAN, RINVOQ, DUPIXENT.

Industry payments across MA — which companies pay providers there.